In our competence center we offer you the possibility to analyze your preclinical and clinical samples with the innovative EliSpot assays for defined readout parameters. We support you in the specific planning, implementation and final documentation of the analytical results according to your requirements. For this purpose we develop and qualify our own as well as customized assays according to international guidelines (FDA / EMA), enabling a robust and high-quality readout for your purposes.

Currently we are working on the GLP (Good Laboratory Practice) certification for the EliSpot analysis to meet corresponding regulatory requirements.

To further match your needs in drug development we closely cooperate with Cellvax (Paris, France) in the field of immunomonitoring of preclinical samples. Cellvax is is a preclinical  CRO which provides innovating drug validation studies both in vitro and in vivo, mainly in Cancer and Osteoarthritis (OA) fields. This allows you to test your immunologically active substance in vivo with immediate immunomonitoring of corresponding samples.